Biomedical Applications of Organometal–Peptide Conjugates
Biomedical Applications of Organometal–Peptide Conjugates
复制标题
DOI:
10.1007/978-3-642-13185-1_8
复制
发表时间:
2010
影响因子:
7.3
通讯作者:
N. Metzler‐Nolte
中科院分区:
文献类型:
--
作者:
N. Metzler‐Nolte
Peptides are well suited as targeting vectors for the directed delivery of metal-based drugs or probes for biomedical investigations. This chapter describes synthetic strategies for the preparation of conjugates of medically interesting peptides with covalently bound metal complexes. Peptides that were used include neuropeptides (enkephalin, neuropeptide Y, neurotensin), uptake peptides (TAT and poly-Arg), and intracellular localization sequences. To these peptides, a whole variety of transition metal complexes has been attached in recent years by solid-phase peptide synthesis (SPPS) techniques. The metal complex can be attached to the peptide on the resin as part of the SPPS scheme. Alternatively, the metal complex may be attached to the peptide as a postsynthetic modification. Advantages as well as disadvantages for either strategy are discussed. Biomedical applications include radiopharmaceutical applications, anticancer and antibacterial activity, metal–peptide conjugates as targeted CO-releasing molecules, and metal–peptide conjugates in biosensor applications.